Hot Keywords
Drug Resistance Mechanisms Epigenetic Resistance in Cancer Therapy Biomarkers Pharmacogenetics of Cancer Liquid Biopsy Targeted Cancer Therapy Non-coding RNAs Kinase Inhibitors ABC Transporters

Topic: Nanotechnology Applied to Overcome Tumor Drug Resistance

A special issue of Cancer Drug Resistance

ISSN 2578-532X (Online)

Submission deadline: 30 Jun 2022

Guest Editor(s)

  • Prof. Xiang-Yang Shi
    College of Chemistry, Chemical Engineering and Biotechnology, Donghua Univeristy, Shanghai, China.

    Website | E-mail

Special Issue Introduction

Chemotherapy is one of the principal treatments for cancer patients in clinics. The chemotherapeutic drugs mostly present a satisfactory effect when they are first exposed to the cancer cells. However, drug resistance always emerges in these tumors. A range of nanodevices or nanostructures with multifunctionalities has been designed to overcome multidrug-resistant cancer cells. Strategies of blocking the drug transporters or inhibiting the expression of P-glycoprotein, integration of multiple drugs within nanomaterials, design of nanodrugs for the targeted killing of cancer stem cells, regulation of the tumor microenvironment, or relieving immunosuppression through nanotechnology-enabled approaches are promising to tackle multidrug resistance of cancer cells. This special issue will cover all aspects of nanotechnology-enabled approaches to treat multidrug-resistant cancer cells.

Submission Deadline

30 Jun 2022

Submission Information

Articles of special issue are free of charge for article processing.
For Author Instructions, please refer to
For Online Submission, please login at
Submission Deadline: 30 Jun 2022
Contacts: Susan Song, Assistant Editor,

Published Articles

© 2016-2023 OAE Publishing Inc., except certain content provided by third parties